Collegium Pharmaceutical Inc COLL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
37.51UNCH (UNCH)
Volume
14,687
Close
37.51UNCH (UNCH)
Volume
285,699
52 week range
20.83 - 40.95
Loading...
  • Open37.80
  • Day High38.32
  • Day Low37.29
  • Prev Close37.51
  • 52 Week High40.95
  • 52 Week High Date03/28/24
  • 52 Week Low20.83
  • 52 Week Low Date07/06/23

Key Stats

  • Market Cap1.227B
  • Shares Out32.71M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change21.86

KEY STATS

  • Open37.80
  • Day High38.32
  • Day Low37.29
  • Prev Close37.51
  • 52 Week High40.95
  • 52 Week High Date03/28/24
  • 52 Week Low20.83
  • 52 Week Low Date07/06/23
  • Market Cap1.227B
  • Shares Out32.71M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change21.86

RATIOS/PROFITABILITY

  • EPS (TTM)0.88
  • P/E (TTM)42.51
  • Fwd P/E (NTM)8.99
  • EBITDA (TTM)324.717M
  • ROE (TTM)24.68%
  • Revenue (TTM)566.767M
  • Gross Margin (TTM)57.55%
  • Net Margin (TTM)8.50%
  • Debt To Equity (MRQ)341.38%

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Collegium Pharmaceutical Inc

 

Profile

MORE
Collegium Pharmaceutical, Inc. is a diversified specialty pharmaceutical company. The Company commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta ER and Nucynta immediate-release (IR), Belbuca, and Symproic in the United States. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is a pain treatment option designed with abuse deterrent properties and uses a technology platform, DETERx. The Nucynta...
Michael Heffernan
Independent Chairman of the Board
Joseph Ciaffoni
President, Chief Executive Officer, Director
Colleen Tupper
Chief Financial Officer, Executive Vice President
Shirley Kuhlmann
Executive Vice President, Chief Administrative Officer, General Counsel, Secretary
Scott Dreyer
Executive Vice President, Chief Commercial Officer
Address
100 Technology Center Dr
Stoughton, MA
02072-4710
United States

Top Peers

SYMBOLLASTCHG%CHG
PCRX
Pacira Biosciences Inc
27.21-0.11-0.40%
ANIP
ANI Pharmaceuticals Inc
67.25+0.14+0.21%
IRWD
Ironwood Pharmaceuticals Inc
8.12-0.18-2.17%
SUPN
Supernus Pharmaceuticals Inc
30.83+0.56+1.85%
HRMY
Harmony Biosciences Holdings Inc
31.57-0.12-0.38%